Brainstorm Cell Therapeutics, Inc. (BCLI)
0.75
+0.03
(+4.02%)
USD |
OTCM |
May 29, 16:00
Brainstorm Cell Therapeutics EPS Diluted (Quarterly) : -0.1928 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovelStem International Corp. | -0.0012 |
| Summit Therapeutics, Inc. | -0.2443 |
| Kezar Life Sciences, Inc. | -0.7838 |
| Protara Therapeutics, Inc. | -0.309 |
| Clene, Inc. | -0.6949 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.127M |
| Total Expenses (Quarterly) | 2.127M |
| Enterprise Value | 9.749M |
| Earnings Yield | -125.5% |
| Normalized Earnings Yield | -125.52 |